S100 as serum tumor marker in advanced uveal melanoma
S100 protein is routinely used as a serum tumor marker in advanced cutaneous melanoma. However, there is scarce and inconclusive evidence on its value in monitoring disease progression of uveal melanoma. In this monocenter study, we retrospectively assessed the connection between documented S100 pro...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 March 2023
|
| In: |
Biomolecules
Year: 2023, Jahrgang: 13, Heft: 3, Pages: 1-10 |
| ISSN: | 2218-273X |
| DOI: | 10.3390/biom13030529 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/biom13030529 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2218-273X/13/3/529 
|
| Verfasserangaben: | Martin Salzmann, Alexander H. Enk and Jessica C. Hassel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1843145391 | ||
| 003 | DE-627 | ||
| 005 | 20230706212827.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230419s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/biom13030529 |2 doi | |
| 035 | |a (DE-627)1843145391 | ||
| 035 | |a (DE-599)KXP1843145391 | ||
| 035 | |a (OCoLC)1389530704 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Salzmann, Martin |d 1993- |e VerfasserIn |0 (DE-588)1193207150 |0 (DE-627)1671866436 |4 aut | |
| 245 | 1 | 0 | |a S100 as serum tumor marker in advanced uveal melanoma |c Martin Salzmann, Alexander H. Enk and Jessica C. Hassel |
| 264 | 1 | |c 14 March 2023 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.04.2023 | ||
| 520 | |a S100 protein is routinely used as a serum tumor marker in advanced cutaneous melanoma. However, there is scarce and inconclusive evidence on its value in monitoring disease progression of uveal melanoma. In this monocenter study, we retrospectively assessed the connection between documented S100 protein levels of patients suffering from stage IV uveal melanoma and the clinical course of disease. Where available, we analyzed expression of S100 in melanoma metastases by immunohistochemistry. A total of 101 patients were included, 98 had available serum S100 levels, and in 83 cases, sufficient data were available to assess a potential link of S100 with the clinical course of the uveal melanoma. Only 12 of 58 (20.7%) patients had elevated serum levels at first diagnosis of stage IV disease. During progressive disease, 54% of patients showed rising serum S100 levels, while 46% of patients did not. Tumor material of 56 patients was stained for S100. Here, 26 (46.4%) showed expression, 19 (33.9%) weak expression, and 11 (19.6%) no expression of S100. Serum S100 levels rose invariably in all patients with strong expression throughout the course of disease, while patients without S100 expression in metastases never showed rising S100 levels. Thus, the value of S100 serum levels in monitoring disease progression can be predicted by immunohistochemistry of metastases. It is not a reliable marker for early detection of advanced disease. | ||
| 650 | 4 | |a S100 protein | |
| 650 | 4 | |a serum tumor marker | |
| 650 | 4 | |a uveal melanoma | |
| 700 | 1 | |a Enk, Alexander |d 1963- |e VerfasserIn |0 (DE-588)1032757140 |0 (DE-627)739272535 |0 (DE-576)166173517 |4 aut | |
| 700 | 1 | |a Hassel, Jessica C. |d 1975- |e VerfasserIn |0 (DE-588)129790702 |0 (DE-627)480399069 |0 (DE-576)29783715X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomolecules |d Basel : MDPI, 2011 |g 13(2023), 3 vom: März, Artikel-ID 529, Seite 1-10 |h Online-Ressource |w (DE-627)735688915 |w (DE-600)2701262-1 |w (DE-576)378494244 |x 2218-273X |7 nnas |a S100 as serum tumor marker in advanced uveal melanoma |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:3 |g month:03 |g elocationid:529 |g pages:1-10 |g extent:10 |a S100 as serum tumor marker in advanced uveal melanoma |
| 856 | 4 | 0 | |u https://doi.org/10.3390/biom13030529 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2218-273X/13/3/529 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230419 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 129790702 |a Hassel, Jessica C. |m 129790702:Hassel, Jessica C. |d 910000 |d 911300 |d 50000 |e 910000PH129790702 |e 911300PH129790702 |e 50000PH129790702 |k 0/910000/ |k 1/910000/911300/ |k 0/50000/ |p 3 |y j | ||
| 998 | |g 1032757140 |a Enk, Alexander |m 1032757140:Enk, Alexander |d 910000 |d 911300 |e 910000PE1032757140 |e 911300PE1032757140 |k 0/910000/ |k 1/910000/911300/ |p 2 | ||
| 998 | |g 1193207150 |a Salzmann, Martin |m 1193207150:Salzmann, Martin |d 910000 |d 911300 |e 910000PS1193207150 |e 911300PS1193207150 |k 0/910000/ |k 1/910000/911300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1843145391 |e 4311239963 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"10 S."}],"recId":"1843145391","origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"14 March 2023"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 20.05.2020"],"id":{"issn":["2218-273X"],"eki":["735688915"],"zdb":["2701262-1"]},"title":[{"title":"Biomolecules","title_sort":"Biomolecules","subtitle":"open access journal"}],"part":{"volume":"13","year":"2023","text":"13(2023), 3 vom: März, Artikel-ID 529, Seite 1-10","extent":"10","issue":"3","pages":"1-10"},"origin":[{"publisher":"MDPI","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisherPlace":"Basel"}],"pubHistory":["1.2011 -"],"disp":"S100 as serum tumor marker in advanced uveal melanomaBiomolecules","physDesc":[{"extent":"Online-Ressource"}],"recId":"735688915"}],"person":[{"display":"Salzmann, Martin","role":"aut","given":"Martin","family":"Salzmann"},{"display":"Enk, Alexander","role":"aut","given":"Alexander","family":"Enk"},{"display":"Hassel, Jessica C.","given":"Jessica C.","role":"aut","family":"Hassel"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 19.04.2023"],"title":[{"title_sort":"S100 as serum tumor marker in advanced uveal melanoma","title":"S100 as serum tumor marker in advanced uveal melanoma"}],"name":{"displayForm":["Martin Salzmann, Alexander H. Enk and Jessica C. Hassel"]},"id":{"doi":["10.3390/biom13030529"],"eki":["1843145391"]}} | ||
| SRT | |a SALZMANNMAS100ASSERU1420 | ||